Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1164/rccm.201601-0169CI http://scihub22266oqcxt.onion/10.1164/rccm.201601-0169CI C5440061!5440061!26991475     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Am+J+Respir+Crit+Care+Med 2016 ; 193 (11): 1213-8 Nephropedia Template TP {{tp|p=26991475|t=2016. Precision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis |pdf=|usr=}}{{26991475}} gab.com Text Precision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis JO: Am J Respir Crit Care Med http://www.kidney.de/pget.php?&tw=1&pmid=26991475 #FOAvip Precision medicine is defined by the National Institute of Health?s Precision Medicine Initiative Working Group as an approach to disease treatment that takes into account individual variability in genes, environment, and lifestyle. There has been increased interest in applying the concept of precision medicine to idiopathic pulmonary fibrosis, in particular to search for genetic and molecular biomarker-based profiles (so called endotypes) that identify mechanistically distinct disease subgroups. The relevance of precision medicine to idiopathic pulmonary fibrosis is yet to be established, but we believe that it holds great promise to provide targeted and highly effective therapies to patients. In this manuscript, we describe the field?s nascent efforts in genetic/molecular endotype identification and how environmental and behavioral subgroups may also be relevant to disease management. Twit Text FOAVip Precision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis ????Am J Respir Crit Care Med http://www.kidney.de/pget.php?&tw=1&pmid=26991475 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26991475 #FOAvip English Wikipedia <ref>{{Cite pmid|26991475}}</ref> Precision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis #MMPMID26991475 Brownell R; Kaminski N; Woodruff PG; Bradford WZ; Richeldi L; Martinez FJ; Collard HR Am J Respir Crit Care Med 2016[Jun]; 193 (11): 1213-8 PMID26991475show ga Precision medicine is defined by the National Institute of Health?s Precision Medicine Initiative Working Group as an approach to disease treatment that takes into account individual variability in genes, environment, and lifestyle. There has been increased interest in applying the concept of precision medicine to idiopathic pulmonary fibrosis, in particular to search for genetic and molecular biomarker-based profiles (so called endotypes) that identify mechanistically distinct disease subgroups. The relevance of precision medicine to idiopathic pulmonary fibrosis is yet to be established, but we believe that it holds great promise to provide targeted and highly effective therapies to patients. In this manuscript, we describe the field?s nascent efforts in genetic/molecular endotype identification and how environmental and behavioral subgroups may also be relevant to disease management. äPrecision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis (epmc).pdf DeepDyve Pubget Overpricing